HIF1a antibody and metabolic reagents for proteins whose level is the regulation
Several central metabolic regulators are controlled by destruction or by cleavage rather than by transcription, and the interesting form exists only under the condition being studied. Collect the sample wrongly and the target is gone before the lysate is made, which is why handling dominates this class of experiment.
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
- the labelling clause behind research use only on an antibody
- 809.10(c)
- the biosafety manual that decides handling for primary material
- BMBL
The figures in this panel are regulation and manual identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Handling and choosing
- Lyse under the condition, not after it. Oxygen sensitive factors are degraded within seconds of returning cells to air. Lysing inside the chamber, or with a denaturing buffer added immediately, is the difference between a band and nothing.
- Detect the cleaved form for processed factors. Factors activated by proteolysis are inactive as the full length precursor. A reagent that sees only the precursor reports the reservoir, not the signal, and both bands should appear on the same blot.
- Extract membranes properly for transporters. Multipass transporters are poorly solubilised by standard buffers and frequently aggregate when heated. Use a membrane protocol and load without boiling where the supplier recommends it.
- Distinguish enzyme amount from flux. An enzyme level is not a rate. Where the claim is about metabolism, pair the blot with a functional measurement, because expression and flux frequently move independently.
- Control with a pathway agonist. A treatment that induces the pathway calibrates the blot and shows the reagent detects the regulated form. For oxygen sensitive targets a chemical stabiliser is a convenient positive control.
Destruction as regulation
Where a protein's level is set by continuous synthesis and rapid destruction, the measurement is a measurement of the handling as much as of the biology. Two laboratories with different collection routines will get different answers from identical cells.
Write the collection into the protocol in seconds, not minutes, and report it. It is the methodological detail that decides whether this class of result reproduces.
Cleavage activated factors need both bands
For factors matured by proteolysis, the informative figure shows the precursor and the processed form together, because the ratio is the activation state. A blot cropped to the processed band throws that away.
Show the full lane, mark both species, and state which the quantification used.
A hif2a antibody and the paralogue with a different tissue range
The two oxygen regulated subunits share domains and are regulated the same way but act in different tissues and drive different genes, so a hif2a antibody needs cross reactivity data against the page's own antigen. The same handling rule applies to both: the protein is degraded within minutes of meeting room air, so the harvest is part of the reagent and a lysate made on the bench reads low for a procedural reason.
A phgdh antibody and the branch point it marks
PHGDH diverts glycolytic carbon into serine synthesis and is amplified in some tumours, so a phgdh antibody is read as an expression difference between lines rather than as a switch, and a stated loading reference is what makes that comparison mean anything. Flux belongs to a labelled tracer measurement, and an antibody supports that claim rather than making it.
An ldhb antibody and the isoform question
Lactate dehydrogenase is a tetramer of A and B subunits whose ratio differs by tissue, so an ldhb antibody must be specific against the A subunit for the reading to mean anything, and a pan reactive clone answers a different question. Both subunits are abundant, so dilution rather than sensitivity is the practical problem and a dilution series shows the signal is in range.
An ogdh antibody and a complex rather than a protein
The oxoglutarate dehydrogenase activity belongs to a multi subunit complex, so an ogdh antibody reports one component and a change in that component does not establish a change in flux. It is a mitochondrial matrix protein, so a fractionation with markers is the preparation, and an activity assay is the companion measurement when metabolism rather than expression is the claim.
A got1 antibody and its mitochondrial counterpart
There are cytosolic and mitochondrial aspartate aminotransferases encoded by different genes, and they are the classic pair to confuse, so a got1 antibody has to state its specificity against the mitochondrial form. A fractionation showing the signal in the cytosolic lane with clean markers is the internal evidence. The two are similar in mass, so a single band settles nothing on its own.
A pgk1 antibody and a glycolytic enzyme used as a reference
PGK1 is abundant and often used as a loading control, which means a pgk1 antibody is asked to be a normaliser and a subject at the same time, and those two uses conflict whenever glycolysis is what changed. If the experiment moves glycolysis, the reference has to be total protein stain instead. A nuclear pool exists under some conditions, so location can be the finding.
A glutaminase antibody and the isoforms one gene splices
Kidney type glutaminase is expressed as two splice forms of different mass and inhibitor sensitivity, so a glutaminase antibody should show which, and the liver type is a separate gene entirely. The protein is mitochondrial, so a matrix marker belongs on the blot. Expression is often compared between lines, which makes a stated loading reference and a positive control the whole basis of the figure.
Common questions
- Why can I never see my hypoxia factor?
- Because it is destroyed almost immediately in oxygen. Lyse inside the hypoxic environment or add denaturing buffer instantly, and use a chemical stabiliser as a positive control to confirm the reagent works.
- Why does my transporter run as a smear with an SREBP1 antibody nearby?
- Glycosylation, aggregation on heating, or both. Load without boiling if the supplier advises it, and treat a broad band as the expected appearance rather than a failure.
- Does enzyme level report metabolic flux?
- No. Flux depends on substrate, allosteric regulation and modification as much as on amount. Pair the blot with a functional readout when the claim is about metabolism.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/hif1a-antibody/.